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ABSTRACT: Adductor pollicis muscle function of a 21-year-old man with
genetically confirmed Brody’s disease (sarcoplasmic reticulum [SR]
-Ca2+ATPase deficiency) was investigated to study the possible effects of
reduced SR-Ca2+ATPase activity on muscle relaxation and force production.
Following maximal electrical activation of the ulnar nerve, tetanic muscle
half-relaxation time was greater in the patient (246 ± 10 ms) than control
subjects (97 ± 4 ms, n = 8). During repetitive activation, there was a similar
decline in maximal shortening velocity in the patient and controls, indicating
a comparable reduction in cross-bridge cycling rate. The finding that the
slowing of relaxation was greater in the patient (329 ms versus 138 ± 20 ms)
suggests that there was a further reduction of SR-Ca2+ATPase activity in the
patient’s muscle during fatigue. Following a voluntary contraction, involun-
tary activity of the antagonist muscles facilitated force decline and masked
the impaired relaxation in the patient. This antagonist-induced relaxation
indicates that it might be difficult to establish impaired muscle relaxation with
voluntary contractions.
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Skeletal muscle contraction is triggered by Ca2+ re-
lease from the sarcoplasmic reticulum (SR). The
binding of Ca2+ to troponin enables cross-bridge in-
teraction and hence force production. During
muscle activation, Ca2+ is pumped back continuously
from the cytosol into the lumen of the SR by an
adenosine triphosphate (ATP)-dependent pump
(SR-Ca2+ATPase). Following muscle activation, relax-
ation is initiated by this Ca2+ pump, which brings the
free Ca2+ concentration in the cytosol back to resting
levels. Selective inhibition of the SR-Ca2+ pump
might slow relaxation, as has been demonstrated in
isolated mouse muscle.18 Fatiguing exercise also is
frequently accompanied by a slowing of muscle re-
laxation. However, the cause of the slowing of
muscle relaxation during fatigue remains unclear
and may in principle be due to a reduced rate of
cross-bridge cycling19 or a slowed Ca2+ handling.5,8
The latter factor would include a decreased rate of
Ca2+ removal from the sarcoplasm due to reduced
activity of SR-Ca2+ATPase in fatigue. The purpose of
the present investigation was to clarify further the
physiological role of SR-Ca2+ATPase during muscle
activity in humans, by studying muscle function in a
patient with a reduced activity of the enzyme caused
by a genetic defect in the SR-Ca2+ATPase gene. In
1969, Brody3 was the first to describe a patient with
SR-Ca2+ATPase deficiency and impaired muscle re-
laxation. Recently, Odermatt et al.13,14 detected mu-
tations in the ATP2A1 gene on chromosome
16p12.1–12.2 that encodes the fast-twitch isoform of
SR Ca2+ATPase (SERCA1), in patients with Brody’s
disease. This permits the diagnosis to be confirmed
at the genetic level. To our knowledge, the diagnosis
has been confirmed with DNA techniques in only
five patients worldwide. We had the opportunity to
carry out exercise testing in one of these cases (pa-
tient no. 4 of Benders et al.1 and patient F1P3 of
Odermatt et al.13) to study the physiological role of
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SR-Ca2+ATPase. The main objective was to study the
possible effects of reduced SR-Ca2+ATPase activity on
relaxation rate, force production, and shortening ve-
locity in fresh and fatigued human muscle. In the
unfatigued muscle, relaxation was expected to be
slower in the patient than in the healthy individuals.
Cross-bridge function, however, should be unaf-
fected by the deficiency, and force production dur-
ing isometric and dynamic muscle contractions
should therefore be normal in the patient. Further-
more, it was hypothesized that during repetitive ac-
tivation the reduced rate of Ca2+ removal from the
cytosol should become further impaired in the pa-
tient, and it was anticipated that this should aggra-
vate the slowing of relaxation during fatigue.
METHODS
The patient was a 21-year-old man who had been
diagnosed with Brody’s disease. He is one of the five
SR-Ca2+ATPase–deficient patients in the world in
whom the genetic cause of the disease has been con-
firmed (patient F1P3 of Odermatt et al.13). A homo-
zygous C592T mutation was found in exon 7 of the
ATP2A1 gene on chromosome 16p12.1–12.2, which
encodes SERCA1.13 Furthermore, SERCA1 activity in
quadriceps muscle samples of this patient was re-
duced to about 40% of normal, and the patient’s
main problem was impaired muscle relaxation fol-
lowing exercise.1 He reported difficulties during
(prolonged) walking and stair climbing, but other-
wise he was healthy and had a physically demanding
job requiring lifting and carrying of heavy objects.
In addition, eight healthy male subjects (20–33
years of age) took part in the experiments. The data
of this group served as a reference for comparison
with the patient’s data. Approval of the Ethical Com-
mittee of the Vrije Universiteit was obtained, and all
subjects gave informed consent.
Experimental Arrangement. The methods for
stimulating the adductor pollicis, recording force,
and imposing length changes are given in detail else-
where.7 Briefly, the subject sat in an adjustable chair
with the left forearm supinated, the hand held hori-
zontally, and the thumb abducted and in contact
with a vertical pin attached to a strain gauge
mounted below the plane of the hand. The entire
hand, with the exception of the thumb, was immo-
bilized with a Perspex plate, which was tightened
down onto a mould fitting into the palm.
The force transducer was attached via a lever sys-
tem to a linear step motor such that linear displace-
ment of the motor was converted into rotation of the
vertical pin around the carpometacarpal joint of the
thumb. When the thumb was fully adducted, its
length axis was parallel to the length axis of the in-
dex finger, and this position was defined as 0° thumb
angle. Because the vertical pin of the force trans-
ducer was placed between the thumb and the index
finger, the smallest thumb angle at which forces
could be measured was 36°. It was possible to in-
crease thumb angle up to 74° (maximal abduction)
before anatomical limits were approached. Thus,
during shortening contractions, the maximal angu-
lar displacement was 38°.
The adductor pollicis muscle was activated by
percutaneous electrical stimulation of the ulnar
nerve at the wrist, with constant current unidirec-
tional square-wave pulses of 100 ms duration (Digi-
timer Ltd, model DS7, Welwyn Garden City, En-
gland).
Electromyogram Recordings. The electromyogram
(EMG) was recorded with two pairs of self-adhering
neonatal electrocardiogram (EKG) Ag-AgCl elec-
trodes (Medi-Trace, Technomed, Beek, The Neth-
erlands). The skin was shaved and cleaned before
placing the electrodes. Two electrodes were placed
on the skin over the adductor pollicis muscle (2.5 cm
between the centers of the electrodes). The other
pair was placed over the abductor pollicis longus and
extensor pollicis brevis muscles (4.5 cm apart). The
EMG signal of the latter pair will be referred to as the
EMG of the abductor muscles. A silver plate (2 × 6
cm) was placed underneath the straps of the stimu-
lation electrodes on the palmar side of the wrist and
served as common-mode electrode. Correct place-
ment of the electrodes was checked with voluntary
abduction and adduction of the thumb. The EMG
signals were amplified, bandpass filtered (10 Hz to 8
kHz), digitized (10 kHz), and stored on computer
disk along with the force and length signal.
Experimental Procedures. During a first session,
subjects were familiarized with the electrical stimu-
lation and the other procedures. Data were collected
only during a second visit. To maintain a constant
muscle temperature, the subject’s hand and arm
were immersed in a water bath at 45°C for 30 min
prior to the test. During the experiment a lamp was
used to maintain skin temperature over the adductor
pollicis at 36.0° ± 0.5°C, measured with a thermo-
couple. In two control subjects, a thermocouple was
inserted in the muscle, and muscle temperature was
found to vary between 35.5°C and 37.0°C during the
experiment.
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Force/Frequency Relationship and Relaxation. Iso-
metric force was measured using 1-s stimulation at a
51° angle between thumb and index finger. A force/
frequency relationship was established using differ-
ent stimulation frequencies (1–200 Hz), the maxi-
mal force obtained at each frequency being
measured. There was 2 min of rest between contrac-
tions. Muscle half-relaxation times (0.5 RT) were cal-
culated to quantify muscle relaxation. The measure-
ment 0.5 RT was defined as the time during which
force decreased from the peak to 50% at the end of
stimulation.
Force/Velocity Relationship. Single-isovelocity con-
tractions (80 Hz stimulation frequency) were in-
duced in the muscle in order to establish a force/
velocity relationship. A force/velocity curve was
constructed using isovelocity contractions at seven
different angular velocities (0°/s, 76°/s, 153°/s,
229°/s, 306°/s, 382°/s, and 458°/s) applied in ran-
dom order. The shortening started during the rise
phase of isometric force development; the muscle
was allowed to shorten at the moment that force
reached a level which was “expected” during the
following shortening phase. This was done so that
forces were constant during the shortening phase.
With a constant force, the length of the series’ elastic
elements (muscle tendons) will not change, and
therefore the shortening velocity of the series elas-
tic elements will be zero. Consequently, the velocity
at which the contractile elements (muscle fibers)
shortened was the velocity imposed upon the entire
muscle–tendon complex. The starting angle and the
timing of the release after the start of stimula-
tion were adjusted such that constancy of force
was reached around the 51° thumb angle at all
applied velocities. The 51° thumb angle is the opti-
mum for force production, although it should be
noted that the length/force relationship of the
adductor pollicis muscle is essentially flat in the
range of thumb angles used in the present study.7
The shortening conditions were established by trial
and error in pilot experiments. Small adjustments
were made for each individual. An example of an
isovelocity (153°/s) shortening contraction is pre-
sented in Figure 1.
At each velocity, the passive force at 51° (thumb
movement without muscle activity) was subtracted
from the total force. The resulting active force (ac-
tive force = total force − passive force) represents the
force exerted by the contractile elements. Thus, all
forces reported in this study are active forces mea-
sured at the 51° thumb angle.
Muscle Fatigue. After the force/velocity mea-
surements in the unfatigued state had been com-
pleted, a cuff around the subject’s upper arm was
inflated to 200 mmHg, and the muscle was then fa-
tigued. The adductor pollicis performed 60 isomet-
ric contractions of 240 ms duration at a 51° thumb
angle. A 50-Hz stimulation frequency was used. This
fatigue protocol was immediately followed by a quick
series of seven randomly ordered contractions (0 to
458°/s). The entire series of isovelocity contractions
in the fatigued state was completed within 20 s. Sub-
sequently the cuff was deflated. After 6 min of rest,
isometric force had recovered to 98 ± 3% of the
prefatigue value. After 12 min a complete force/
velocity relationship was obtained. Recovered forces
of the patient and the control subjects were always
within 5% of the prefatigue values at all velocities.
Original Force Traces. In several figures, original
force traces of the patient are presented and com-
pared with those of one of the healthy subjects, se-
lected because maximal isometric force of his adduc-
tor pollicis muscle was similar to that of the patient.
Data Analysis and Statistics. At each velocity, ac-
tive forces at the 51° thumb angle were used to con-
struct force/velocity relationships (fresh and fa-
FIGURE 1. Example of an isovelocity shortening contraction at
153°/s. Following passive abduction to a 64° thumb angle (top
panel), the muscle was electrically stimulated (80 Hz), as indi-
cated by the black bar above the time axis. After a short isometric
phase, during which force increased (to 44 N), the thumb was
allowed to adduct at constant velocity (153°/s). This sequence
was repeated without electrical stimulation, thus with a passive
muscle (lower force trace). Active muscle force was obtained by
subtracting the passive force from the total force at a 51° thumb
angle. Note the different scaling left and right from the break in
the time axis.
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tigued) of the muscle. Data points were fitted (least
squares) to a hyperbola as described by Hill.10 The
results of the healthy individuals are presented as
means ± SD.
RESULTS
At the start of the experiment, the patient was in-
structed to maximally adduct his thumb for a few
seconds and to stop squeezing on instruction of the
experimenter. Although there were no obvious
problems with respect to the relaxation of force (Fig.
2A) substantial EMG activity was recorded from the
abductor muscles during relaxation (Fig. 2A). Even
after several trials, the patient was unable to stop
adducting his thumb during a voluntary contraction
without the use of his abductors.
When the patient’s adductor pollicis was electri-
cally stimulated, muscle relaxation was clearly im-
paired (Figs. 2B and 3). Figure 2B shows that during
the relaxation phase, the EMG of the patient’s ad-
ductor and abductor muscles was silent. In Figure
2C, the results are shown for a similar contraction as
in Figure 2B, except that the patient was instructed
to use his abductors immediately after cessation of
the electrical pulse train in order to bring force back
to baseline more quickly. In this way the patient’s
“natural” response following a voluntary contraction
(Fig. 2A) was mimicked. Indeed, in both Figs. 2A
and 2C, a fast (apparently normal) decline of force
was accompanied by substantial EMG activity of the
abductor muscles.
As expected, tetanic (80 Hz stimulation fre-
quency) 0.5 RT was slower in the patient (246 ± 10
ms, mean of 4 tetani) compared with the control
subjects (97 ± 4 ms; range, 89–103 ms). The slower
relaxation was already visible following a twitch of
the muscle (Figs. 3B and 3C). Twitch 0.5 RT was two
times longer in the patient (112 ± 4 ms, mean of six
twitches) compared with control values (54 ± 6 ms;
range, 42–60 ms). Furthermore, the forces obtained
with submaximal stimulation frequencies were
higher in the patient compared with control subjects
(Fig. 3). With 10 Hz stimulation (Fig. 3), forces in
the patient and healthy subjects, respectively, were
69% and 21 ± 6% of maximum force (Fig. 4). The
twitch/tetanic force ratio was 0.17 in the patient
compared with 0.11 ± 0.01 in the controls. Conse-
quently, the patient’s force/frequency relationship
was shifted to the left compared with control subjects
(Fig. 4).
Due to the slow relaxation, the patient’s thumb
force failed to reach the baseline after the first con-
traction of the fatigue test (Fig. 5). Muscle relaxation
in the control subjects also became considerably
slower during the fatigue test. In these healthy indi-
viduals, however, force declined to baseline values
between contractions up until the end of the test
(Fig. 5). There was a 45% force decline in the pa-
tient’s muscle (Fig. 5) compared with a decrease of
22 ± 5% in control subjects. Thus, there seems to be
an increased fatigability in the patient’s muscle.
However, the (isometric) force obtained in the fa-
tigue state immediately following the fatigue test
(with the blood flow still occluded) was similar com-
pared with control values (Figs. 6 and 7).
The fatigue test caused an increase in tetanic 0.5
RT of 329 ms (from 246 ms to 575 ms) in the patient
and of 138 ms (from 97 ± 4 ms to 235 ± 42 ms) in
FIGURE 2. Maximal voluntary contraction of the adductor pollicis
muscle in the patient. Forces (top) and EMG of the adductor
pollicis (middle) and the antagonist muscles (bottom) of the pa-
tient are shown for: a 5 s maximal voluntary contraction (A), a 1-s
electrically induced contraction (B), and a 1-s electrically induced
contraction followed by voluntary effort in order to facilitate force
relaxation (C). Relaxation in (B) clearly is impaired compared
with the control subject (dotted trace); EMG signals in the patient
remained (almost) silent during relaxation. Force relaxation ap-
pears to be normal in both (A) and (C). Note, however, that in
both contractions there was substantial EMG activity of the an-
tagonist muscles during relaxation.
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controls. Examples of tetanic force signals in the
fresh and fatigued adductor pollicis of the patient
and a control subject are shown in Figure 6. In both
the fresh and fatigued muscle, relaxation was im-
paired in the absence of any electrical activity of the
muscle, as illustrated by the lack of EMG activity dur-
ing relaxation (Fig. 6). In accordance with our hy-
pothesis, the force-generating capacity of the muscle
was apparently not impaired in the patient. Over the
entire range of shortening velocities, both in the
fresh and fatigued state, force of the adductor polli-
cis of the patient was within the range of controls.
Consequently, the patient’s force/velocity relation-
ships (fresh and fatigued muscle) were similar to
those of the healthy subjects (Fig. 7).
DISCUSSION
This study is the first to investigate the physiological
consequences of SR-Ca2+ATPase deficiency for hu-
man skeletal muscle function in detail. An unex-
pected finding was that force quickly returned to
baseline values after voluntary effort due to activa-
tion of the antagonist muscles (Fig. 2A). This phe-
nomenon, which we designate antagonist-induced
relaxation, occurred automatically, even when the
FIGURE 4. Force/frequency relationships. Maximal thumb ad-
duction force as a function of stimulation frequency (force at 200
Hz = 100%) in the patient (open squares) and control subjects
(closed circles, mean ± SD).
<
FIGURE 3. 10-Hz tetanic and twitch forces. Tetanic force (1-s
contraction, 10-Hz stimulation frequency) at the 51° thumb angle
(A) and twitch force (B) of the patient (bold traces) and a control
subject with similar maximal thumb adduction strength (± 73 N).
(C) Twitch forces are normalized (peak = 100%); note the much
broader twitch of the patient.
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patient tried hard not to use the antagonist muscles
during relaxation. It is likely that antagonist-induced
relaxation has become a strategy of the patient’s
neuromuscular system, allowing him to open his
hand quickly, even though his agonist muscles are
still exerting force. Although this is clearly a very
functional adaptation, it will also increase the work-
load placed upon the shortening muscles during cy-
clic activities such as walking and stair climbing. Dur-
ing such activities, antagonist muscles have to
forcefully stretch force-exerting agonist muscles.
Consequently, the energy costs and metabolic
changes are likely to increase during cyclic activities.
Therefore, increased metabolic changes may explain
the aggravation of clinical symptoms, such as an en-
hanced fatigability, in other SR-Ca2+ATPase–
deficient patients during exercise.2–4,12,15,16,20
With electrically induced contractions, 2.5-fold
longer 0.5 RTs were found in the patient compared
with healthy subjects (Figs. 2 and 6). The slower rate
of relaxation probably accounts for the increased
rate of fusion and the higher forces at low frequen-
cies of stimulation (Figs. 3 and 4) in the patient’s
muscle. These findings are in accordance with the
notion that there is a prolongation of the active state
following contraction, caused by a slower re-uptake
of Ca2+ from the sarcoplasm due to a reduced func-
tion of the SR-Ca2+ pump. Support for this explana-
tion is offered by the finding that selective inhibition
of the SR-Ca2+ pump in isolated mouse muscle fibers
leads to a significant slowing of relaxation.18 How-
ever, it cannot be excluded that some other mecha-
nism may have led to or contributed to the slowed
relaxation in our patient.
FIGURE 5. Force during repetitive isometric contractions. Origi-
nal force traces during 60 isometric contractions (240 ms dura-
tion; 50 Hz stimulation frequency; one contraction each second)
of the patient (top) and a control subject (bottom).
FIGURE 6. Isometric force in fresh and fatigued muscle. Isomet-
ric (1-s contractions; 80 Hz) adductor pollicis muscle force (top) of
a healthy subject (thin traces) and the patient (bold traces) in the
fresh and fatigued (slower relaxation) state. Electromyograph sig-
nals of the patient’s adductor pollicis muscle in the fresh (middle)
and fatigued (bottom) state are also shown.
FIGURE 7. Force/velocity relationships in fresh and fatigued ad-
ductor pollicis muscle. Force as a function of angular velocity in
the fresh (circles) and fatigued (squares) adductor pollicis muscle
of the patient (closed symbols, dotted lines) and healthy subjects
(open symbols, mean ± SD).
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It might be argued that the impaired relaxation
and twitch potentiation in the patient could also be
explained by an increased Ca2+ loading of parvalbu-
mins, which would diminish the capacity of parval-
bumins as a soluble relaxing factor following stimu-
lation. Consequently, the free Ca2+concentration
following activation would remain higher in the pa-
tient’s muscle, which in theory could account for the
twitch potentiation and the slowed relaxation. Al-
though there is some evidence that parvalbumins
speed up muscle relaxation in cold-blooded animals
at low muscle temperatures,11 and to some extent
also in small mammals, such as the mouse, at room
temperature,18 we are unaware of studies demon-
strating that parvalbumins play an important role in
human muscle relaxation at 36°C. Moreover, the
parvalbumin concentration in human muscle is very
low compared with fast-twitch mouse muscle (<0.001
g/kg versus 4.9 g/kg, respectively9). Therefore, al-
though we cannot exclude a possible role of parval-
bumins in our measurements, we believe that the
impaired relaxation and the twitch potentiation in
our patient are the direct consequence of the re-
duced SR-Ca2+ATPase activity.
An interesting finding was that we were unable to
confirm the impaired relaxation found by Brody3
following voluntary activation of the adductor polli-
cis muscle in a SR-Ca2+ATPase–deficient patient.
Furthermore, twitch relaxation was impaired in our
patient, whereas Brody3 reported a normal (63 ms)
twitch 0.5 RT of the adductor pollicis muscle in his
patient. Such discrepancies may have been caused by
the fact that the patient investigated by Brody may
not have had a defect in the SR-Ca2+ATPase gene. To
our knowledge, the defect in the SERCA1 gene has
not been investigated at the DNA level in Brody’s
patient (personal communication, D.H. MacLen-
nan). Zhang and coworkers21 have previously inves-
tigated at least three cases of presumed Brody’s dis-
ease where no mutation could be found in the
SERCA1 gene. In such patients, the explanation for
the low SR-Ca2+ATPase activity measured in muscle
samples using biochemical methods is sought in de-
fects in other proteins like sarcolipin, which are as-
sociated with SERCA1.14 For this reason we have cho-
sen to investigate muscle function in a genetically
confirmed case of SR-Ca2+ATPase deficiency.
There are no indications in the literature that
maximal force production during a single short te-
tanic contraction depends on SR-Ca2+ATPase activ-
ity. Therefore, the patient’s ability to exert force,
under isometric as well as under dynamic conditions,
was not expected to be affected by the disease. In-
deed, maximal isometric force and the force/
velocity relationship of the patient’s adductor polli-
cis muscle were very similar to that of the control
subjects. However, because the physiological cross
section of the muscles was not obtained, it cannot be
excluded that the specific tension (= force/cross sec-
tion) of the patient’s muscle was different. Neverthe-
less, our findings strongly suggest that the clinical
symptoms in the patient were strictly related to the
deficiency in SR-Ca2+ATPase and were not caused by
other malfunctions at the cross-bridge level.
During the fatigue test, isometric force decreased
more in the patient than in controls. This may indi-
cate that SR-Ca2+ release decreased during repetitive
activation of the patient’s muscle. The differences in
isometric force production between the patient and
control subjects disappeared within seconds follow-
ing the fatigue test, showing that force recovered to
some extent in the deficient muscle in spite of the
occluded blood flow. In the fatigued state, there was
more rest between contractions than during the fa-
tigue test, which may have improved SR Ca2+ loading
and consequently Ca2+ release during the next teta-
nus. In addition, the higher-stimulation frequency
(80 Hz) used following the test, compared with the
50 Hz applied during the test may have restored Ca2+
release in the patient’s muscle to the level required
for maximal force production under those circum-
stances. There may, however, be other explanations
for the more pronounced decline of force in the
patient’s muscle during the fatigue test, such as com-
partmentalization of metabolites.
A leftward shift of the force/velocity relationship
during repetitive activation has been found in iso-
lated muscle and single-fiber preparations, indicat-
ing that not only isometric force production but also
cross-bridge cycling rate (Vmax) decreases during fa-
tigue.6,17 The present results on human muscle sup-
port these previous findings, which suggested that a
decreased cross-bridge detachment rate is an impor-
tant cause for the slowing of relaxation observed dur-
ing fatigue. However, Vmax and force production de-
creased to similar extents in the fatigued muscle of
the patient and control subjects, whereas muscle re-
laxation was more affected in the patient. These re-
sults indicate that the changes in cross-bridge func-
tion during fatigue were similar in the patient and
control subjects. The findings also suggest that in the
deficient muscle it is likely that in addition to a
slowed cross-bridge detachment rate, an impaired
rate of SR Ca2+ pumping contributed to the fatigue-
induced slowing of relaxation.
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CONCLUSION
Relaxation was severely prolonged in the electrically
stimulated adductor pollicis muscle of a SR-
Ca2+ATPase–deficient patient. Following voluntary
activation, the patient used his antagonist muscles to
speed up force decline (antagonist-induced relax-
ation). The deficiency did not affect cross-bridge
function, as was demonstrated by the similar force/
velocity relationships of the patient muscles and con-
trol muscles. During repetitive activation, the reduc-
tion in maximal shortening velocity, indicative for
the maximal rate of cross-bridge cycling, was similar
in the controls and the patient. This similarity was
expected to cause a comparable slowing of relax-
ation in the patient and controls. However, the slow-
ing of relaxation in the fatigued muscle of the pa-
tient was greater, which could have been due to a
further reduction of SR-Ca2+ATPase activity during
repetitive activation. Although the data are obtained
from a single patient, the present findings confirm
the generally accepted physiological role of SR-
Ca2+ATPase during muscle activity.
The authors thank Prof. Dr. H.F.M. Busch for the opportunity to
investigate the patient.
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